Allergan Inc (AGN.N)

AGN.N on New York Stock Exchange

189.44USD
30 Oct 2014
Price Change (% chg)

$2.67 (+1.43%)
Prev Close
$186.77
Open
$186.52
Day's High
$189.83
Day's Low
$185.76
Volume
221,827
Avg. Vol
304,156
52-wk High
$192.60
52-wk Low
$88.34

AGN.N

Chart for AGN.N

About

Allergan, Inc. is a multi-specialty health care Company focused on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products. The Company’s segments include specialty pharmaceuticals, which produces a range of pharmaceutical products, including ophthalmic products for dry eye,... (more)

Overall

Beta: 0.72
Market Cap (Mil.): $56,379.90
Shares Outstanding (Mil.): 297.61
Dividend: 0.05
Yield (%): 0.11

Financials

  AGN.N Industry Sector
P/E (TTM): 44.15 33.49 34.41
EPS (TTM): 4.29 -- --
ROI: 13.65 18.10 17.37
ROE: 19.71 18.76 18.18
Search Stocks

Valeant ready to raise Allergan bid to at least $200/share

- Valeant Pharmaceuticals International Inc on Monday said in a letter to Allergan Inc's board of directors that it was prepared to raise its offer to at least $200 per share but stopped short of doing so.

27 Oct 2014

UPDATE 3-Valeant says ready to raise Allergan bid to at least $200/share

Oct 27 - Valeant Pharmaceuticals International Inc on Monday said in a letter to Allergan Inc's board of directors that it was prepared to raise its offer to at least $200 per share but stopped short of doing so.

27 Oct 2014

Valeant says ready to raise Allergan bid to at least $200/share

Oct 27 - Valeant Pharmaceuticals International Inc said it is prepared to improve its offer for Allergan Inc to at least $200 per share.

27 Oct 2014

COLUMN-New details in Allergan anti-takeover campaign: Frankel

(The opinions expressed here are those of Alison Frankel, a columnist for Reuters.)

24 Oct 2014

Stronger oil stocks and surge in Shire lift UK's FTSE

LONDON, Oct 21 - Gains in big oil companies and drugmaker Shire lifted Britain's top equity index on Tuesday, which extended a rebound after falling to 15-month lows last week.

21 Oct 2014

Allergan says it stands by statements on Valeant

BOSTON - Allergan Inc said on Tuesday it saw no evidence to support claims by hostile suitors Valeant Pharmaceuticals and hedge fund Pershing Square Capital Management that its chief executive officer had spearheaded a campaign to spread misinformation.

21 Oct 2014

UPDATE 1-Allergan says it stands by statements on Valeant

BOSTON, Oct 21 - Allergan Inc said on Tuesday it saw no evidence to support claims by hostile suitors Valeant Pharmaceuticals and hedge fund Pershing Square Capital Management that its chief executive officer had spearheaded a campaign to spread misinformation.

21 Oct 2014

Allergan says it stands by statements on Valeant

BOSTON, Oct 21 - Allergan Inc said on Tuesday that it believes there is no evidence to support Valeant Pharmaceuticals and hedge fund Pershing Square Capital Management's claims that its chief executive officer spearheaded a campaign to spread misinformation about Valeant.

21 Oct 2014

Gains in oil stocks and Shire lift UK's FTSE

* FTSE 100 up 1.4 pct, continues rebound off 15-month lows

21 Oct 2014

Gains in oil stocks and Shire lift UK's FTSE

LONDON, Oct 21 - A rise in major oil stocks and drugmaker Shire helped Britain's top equity index extend its rebound on Tuesday after falling to 15-month lows last week.

21 Oct 2014

Competitors

  Price Change
Astellas Pharma Inc (4503.T) ¥1,699 +61.50
Santen Pharmaceutical Co Ltd (4536.T) ¥6,560 +240.00
Lupin Limited (LUPN.NS) Rs1,369.05 +23.75
Nestle SA (NESN.VX) CHF69.90 +0.45
Johnson & Johnson (JNJ.N) $107.04 +1.48
Pfizer Inc. (PFE.N) $29.84 +0.35
Novartis AG (NOVN.VX) CHF89.00 +1.30
High Tech Pharm Co.,Ltd. (106190.KQ) ₩14,600.00 --
Merck & Co., Inc. (MRK.N) $57.31 +1.11
Roche Holding Ltd. (ROG.VX) CHF285.60 +2.20

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: S&P Capital IQ – STARS Reports
$127.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks